Clinical outcomes and prognostic factors in patients with stage II-III breast cancer treated with neoadjuvant chemotherapy followed by surgery and postmastectomy radiation therapy in the modern treatment era

Clinical outcomes and prognostic factors in patients with stage II-III breast cancer treated with neoadjuvant chemotherapy followed by surgery and postmastectomy radiation therapy in the modern treatment era

Purpose: There are no randomized studies on the indication for postmastectomy radiation therapy (PMRT) in patients who receive neoadjuvant chemotherapy (NAC) followed by a mastectomy. The aim of this study was to determine clinical outcomes and identify reliable prognostic factors in patients with l...

Full description

Bibliographic Details
Main Authors: Naomi Nakajima, MD, PhD, Masahiko Oguchi, MD, PhD, Yasuko Kumai, MD, Masahiro Yoshida, MD, Hirotaka Inoda, MD, Yasuo Yoshioka, MD, PhD, Takuji Iwase, MD, Yoshinori Ito, MD, PhD, Futoshi Akiyama, MD, PhD, Shinji Ohno, MD, PhD
Format: Article
Language:English
Published: Elsevier 2018-07-01
Series:Advances in Radiation Oncology
Online Access:http://www.sciencedirect.com/science/article/pii/S2452109418300691

Internet

http://www.sciencedirect.com/science/article/pii/S2452109418300691

Similar Items